×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| MARKSANS PHARMA LTD. | 7096.95 | 1050.67 | 6818.46 | 2.31 | 10,244 | 27.9 |
| Vijaya Diagnostic Centre Limit | 1612.46 | 335.33 | 1562.55 | 3.26 | 10203 | 71.9 |
| Jupiter Life Line Hospitals Li | 3289.39 | 525.14 | 3206.38 | 8.01 | 9772 | 50.8 |
Marksans Pharma Ltd., with Security Code 524404, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 159.1 | 170.2 | 172.7 | 153.0 | 182.0 | 204.6 | 241.3 | 225.1 | 254.5 | 308.6 |
| Expenses | 147.5 | 136.5 | 148.9 | 130.3 | 155.3 | 167.4 | 199.4 | 191.3 | 213.3 | 256.4 |
| Operating Profit | 11.6 | 33.8 | 23.8 | 22.7 | 26.8 | 37.3 | 42.0 | 33.9 | 41.3 | 52.3 |
| OPM % | 7.29% | 19.84% | 13.79% | 14.84% | 14.7% | 18.22% | 17.39% | 15.06% | 16.21% | 16.94% |
| Other Income | 19.4 | 21.0 | 15.7 | 4.3 | 32.6 | 15.9 | 1.3 | 12.2 | 8.2 | 31.4 |
| Interest | 0.8 | 1.3 | 0.8 | 0.7 | 0.3 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 |
| Depreciation | 4.5 | 4.5 | 4.2 | 3.5 | 4.7 | 8.5 | 8.4 | 7.5 | 6.8 | 7.0 |
| Profit before tax | 25.7 | 49.0 | 34.5 | 22.8 | 54.4 | 44.5 | 34.6 | 38.4 | 42.3 | 76.3 |
| Tax % | 25.3% | 17.9% | 25.7% | 22% | 18.8% | 29.7% | 26.9% | 14.1% | 24.3% | 17.2% |
| Net Profit | 19.2 | 40.2 | 25.6 | 17.8 | 44.2 | 31.3 | 25.3 | 33.0 | 32.0 | 63.2 |
| EPS in Rs | 0.47 | 1 | 0.63 | 0.43 | 0.98 | 0.69 | 0.56 | 0.73 | 0.71 | 1.39 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 452.6 | 479.8 | 486.0 | 500.0 | 531.2 | 586.1 | 560.0 | 590.6 | 641.9 | 681.8 |
| Expenses | 372.3 | 403.2 | 376.4 | 398.1 | 417.3 | 453.1 | 450.4 | 462.2 | 506.2 | 543.1 |
| Operating Profit | 80.3 | 76.6 | 109.5 | 102.0 | 113.9 | 133.0 | 109.6 | 128.4 | 135.7 | 138.8 |
| OPM % | 17.7% | 16% | 22.5% | 20.4% | 21.4% | 22.7% | 19.6% | 21.7% | 21.1% | 20.4% |
| Other Income | 14.2 | 17.7 | 11.0 | 10.1 | 19.0 | 4.8 | 16.5 | 14.9 | 11.1 | 27.8 |
| Interest | 2.5 | 2.4 | 2.4 | 1.6 | 1.6 | 3.2 | 4.8 | 2.9 | 2.6 | 2.7 |
| Depreciation | 14.1 | 12.7 | 13.9 | 13.7 | 17.6 | 22.0 | 21.1 | 20.4 | 19.5 | 20.7 |
| Profit before tax | 77.8 | 79.2 | 104.2 | 96.8 | 113.8 | 112.7 | 100.3 | 120.0 | 124.6 | 143.3 |
| Tax % | 22.8% | 21.3% | 20.6% | 27.3% | 26.3% | 26.4% | 22.6% | 25.8% | 21.5% | 26.7% |
| Net Profit | 60.1 | 62.3 | 82.7 | 70.4 | 83.9 | 83.0 | 77.6 | 89.1 | 97.8 | 105.1 |
| EPS in Rs | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 15% |
| 3 Years: | 12% |
| TTM: | 41% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 25% |
| 3 Years: | 11% |
| TTM: | 55% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 64% |
| 3 Years: | 67% |
| 1 Year: | 43% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 17% |
| 3 Years: | 17% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 33% |
| 3 Years: | 10% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 64% |
| 3 Years: | 67% |
| 1 Year: | 43% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|